0 Commentarii
0 Distribuiri
827 Views
0 previzualizare
Sponsor
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
-
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
2025 Cystic Fibrosis Pipeline: Key Clinical Trials and Biotech AdvancementsWhat is the projected growth rate (CAGR) of the Global Vascular Endothelial Growth Factor Receptor Inhibitors Market from 2024 to 2031, and what is the market value expected to change by 2031? Global Vascular Endothelial Growth Factor Receptor (VEGFR) Inhibitors Market reached US$14.12 billion in 2024 and is expected to reach US$22.34 billion by 2033, growing at a CAGR of 5.9 % during the...0 Commentarii 0 Distribuiri 2K Views 0 previzualizare
-
Biotech & CRISPR Boost Seed Industry InnovationThe global vegetable seed market is poised for robust growth, projected to grow from USD 8.45 billion in 2024 to USD 15.2 billion by 2033, at a CAGR of ~6.5%. Vegetable-seed-market Request a sample copy of the research report:https://www.datamintelligence.com/download-sample/vegetable-seed-market Market Overview & Core Drivers Current Size & Forecast DataM...0 Commentarii 0 Distribuiri 3K Views 0 previzualizare
-
Biotech Partnerships Accelerate FTD *** DevelopmentThe frontotemporal disorders treatment market, addressing rare but impactful neurodegenerative diseases, is poised for steady growth. Valued at USD 343.8 million in 2022, it is projected to reach USD 451.4 million by 2028, up at a 4.6% CAGR (2022–28). Frontotemporal Disorders Treatment Market Request a sample copy of the research report:...0 Commentarii 0 Distribuiri 3K Views 0 previzualizare
-
Lysosomal Storage Disease Treatment Market to Reach USD 6.80 Billion by 2034 Amid Biotech Innovation and Growing Rare Disease AwarenessThe global lysosomal storage disease treatment market, valued at USD 4.50 billion in 2024, is poised to expand steadily over the next decade. With a compound annual growth rate (CAGR) of 4.2% from 2025 to 2034, the market is projected to reach USD 6.80 billion by 2034, according to recent industry analysis. This growth is fueled by increasing diagnosis rates, the rise...0 Commentarii 0 Distribuiri 1K Views 0 previzualizare
-
Plasmid Purification Market Forecast: Strategic Insights for Investors and Biotech FirmsMarket Size and Growth Overview The global Plasmid Production Facilities has evolved into a cornerstone of the modern biotechnology ecosystem, underpinning breakthroughs in gene therapy, vaccine development, and molecular biology research. Plasmid purification is the process of isolating pure, high-quality plasmid DNA (pDNA) a key raw material used in recombinant protein production,...0 Commentarii 0 Distribuiri 326 Views 0 previzualizare
-
U.S. Advances RNAi Research with FDA Approvals and Biotech FundingThe global RNAi Technology Market was valued at USD 1.6 billion in 2022 and is projected to reach USD 3.6 billion by 2031, growing at a CAGR of 10.3% during the forecast period 2024–2031. RNA interference (RNAi) utilizes small nucleic acid fragments to silence genes post-transcriptionally, enabling the treatment of cancer and other complex disorders with high specificity. This technique...0 Commentarii 0 Distribuiri 2K Views 0 previzualizare
-
U.S. Biotech Surge Fuels Exosome-Based Liquid Biopsy DevelopmentThe global exosomes market reached US$ 1.3 billion in 2023 and is projected to grow to US$ 2.7 billion by 2031, at a CAGR of 15.6% during the forecast period 2024–2031, driven by expanding applications in oncology, immunotherapy, and regenerative medicine. Exosomes small vesicles ranging from 30 to 200 nm—mediate critical intercellular signaling, including EGFR-related mechanisms...0 Commentarii 0 Distribuiri 3K Views 0 previzualizare
-
Active Pharmaceutical Ingredients (API) Market Forecast to Reach USD 399.17 Million by 2033Active Pharmaceutical Ingredients (API) Market Overview The global active pharmaceutical ingredients (api) market size was valued at USD 235.27 million in 2024 and is anticipated to grow from USD 249.5 million in 2025 to reach USD 399.17 million in 2033, growing at a CAGR of 6.05% during the forecast period (2025–2033). Download Exclusive Research...0 Commentarii 0 Distribuiri 1K Views 0 previzualizare
-
Automation and AI Power Next Wave of Microbial Culture InnovationThe global Microbiology Culture Market reached USD 20.38 billion in 2024 and is projected to surge to USD 40.20 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.2% from 2025 to 2033. This rapid expansion is being driven by rising infectious disease incidence, biotechnology advancements, food safety testing demands, and the need for high-throughput microbial ***ysis. Market...0 Commentarii 0 Distribuiri 3K Views 0 previzualizare
-
Cystic Fibrosis Market Size to Hit USD 26.58 Billion with 11.8% CAGR by 2031, Report by DataM IntelligenceCystic Fibrosis is a genetic disorder that primarily affects the lungs, pancreas, and other organs, leading to severe respiratory and digestive complications. It is caused by mutations in the CFTR gene, which disrupts chloride ion transport, resulting in thick mucus buildup in organs. The global prevalence of cystic fibrosis, coupled with its chronic nature, underscores the need for...0 Commentarii 0 Distribuiri 873 Views 0 previzualizare
-
Digital Monitoring Tools Improve Huntington’s Disease ManagementThe global Huntington’s disease (HD) market is forecast to reach USD 1.9 billion by 2031, up from USD 961 million in 2023, growing at a compound annual growth rate (CAGR) of 9.1% during the forecast period. Fueled by increasing clinical trials, breakthroughs in RNA interference, and growing awareness, the HD market is poised for significant transformation. Huntington’s disease is a...0 Commentarii 0 Distribuiri 2K Views 0 previzualizare
-
Green Enzymes and Bioplastics Propel Industrial SegmentThe global Recombinant DNA (rDNA) Technology Market is on track to grow from an estimated USD 798 billion in 2023 to USD 1,395 billion by 2032, registering a steady compound annual growth rate (CAGR) of 6.4%. The market is being propelled by expanding applications in pharmaceuticals, agriculture, industrial biotechnology, and environmental sustainability. Market Snapshot 2023 Market Size:...0 Commentarii 0 Distribuiri 2K Views 0 previzualizare
-
Novo Nordisk Challenges Pfizer in a High-Stakes Battle for MetseraThe global obesity drug market has erupted into a fierce competition following the Pfizer Metsera acquisition, which has now drawn a bold counteroffer from Novo Nordisk. What began as a quiet business move has escalated into an all-out bidding war after Novo Nordisk made an unsolicited $9 billion proposal to purchase Metsera—just days after Pfizer’s initial announcement. This...0 Commentarii 0 Distribuiri 383 Views 0 previzualizare
-
Unlocking Cures: The Rise of Gene Therapies in Rare Neurological DisordersThe rare neurological disease drugs market is gaining significant traction due to increasing global awareness, technological advancements in diagnostics, and the growing pipeline of orphan drugs. These diseases, though individually rare, collectively impact millions of patients worldwide and require highly specialized treatments. With governments and pharmaceutical companies focusing more on...0 Commentarii 0 Distribuiri 2K Views 0 previzualizare
Sponsorizeaza Paginile
Sponsor
English
Arabic
עברית
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek